Navigation Links
OncoGenex Pharmaceuticals to Webcast Financial Results for Fourth Quarter and Fiscal Year 2008 and Provide Outlook for 2009
Date:3/4/2009

BOTHELL, WA and VANCOUVER, March 4 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the Company's fourth quarter and fiscal year 2008 financial results will be released on Wednesday, March 11, 2009, and that the Company will host a conference call and live webcast at 4:30 p.m. EDT that afternoon. Management will discuss the company's financial results and provide a 2009 corporate outlook.

A live webcast and slide presentation will be available through the Events and Presentations Web page found in the Investors Relations section of the OncoGenex Web site at http://ir.oncogenex.com. Alternatively, you may access the live conference call by dialing 877-874-1569 (U.S. & Canada) or 719-325-4767 (International). A webcast replay will be available approximately two hours after the call and will be archived at the same Web location for 90 days.

About OncoGenex Pharmaceuticals

OncoGenex Pharmaceuticals is a biopharmaceutical company committed to the development and commercialization of new therapies that address unmet needs in the treatment of cancer. OncoGenex has a deep oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OGX-011, the lead candidate currently completing five Phase 2 clinical studies in prostate, lung and breast cancers, is designed to inhibit the production of a specific protein associated with treatment resistance; OGX-427 is in Phase 1 clinical development; SN2310 has completed the Phase 1 clinical trial; and CSP-9222 and OGX-225 are currently in pre-clinical development. More information about OncoGenex is available at www.oncogenex.com.


'/>"/>
SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer
2. Sonus Pharmaceuticals and OncoGenex Technologies to Merge
3. OncoGenex to present at the Needham & Company 7th Annual Biotechnology & Medical Technology Conference
4. OncoGenex increases economic interest in lead cancer drug OGX-011
5. OncoGenex receives completed Special Protocol Assessment for primary registration study of lead drug candidate OGX-011
6. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
7. FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals Lead Product Candidate OGX-011
8. OncoGenex Pharmaceuticals announces out-license of TOCOSOL Paclitaxel to Eagle Pharmaceuticals
9. OncoGenex To Present At The BioContact Quebec 2008 Annual Conference
10. OncoGenex Achieves Key Regulatory Milestone for Lead Product Candidate, OGX-011
11. OncoGenex Pharmaceuticals to Release Third Quarter Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ewswire/ - Cytochroma today announced the appointm... Dr. Moldt will replace Mr. Ulrik Spork as the Nov...umber of Board members remains unchanged at six me... Moldt to the board and look forward to benefiting...ntinues to make progress in becoming a leading CKD...
(Date:11/24/2009)...an . , Whether it,s CD packaging, containers...cy Identification) are increasingly finding their ...abel objects or goods and identify them automatica...n read and process the data contained in the label...ction conditions of up to 100 degrees Celsius. But...
(Date:11/24/2009)...swire/--TwomoreprestigiousuniversitieshavejoinedBi...areerssiteforlifescienceprofessionals. ,, North...oard,joining28othermajorlifesciencetrainingInstitu...,isonlyforpost-graduatesinthelifesciences.Whilethe...,BioCareerCenteristheonlyonethatserveslifesciencep...
(Date:11/24/2009)...e employment grew by 29,000 jobs in October, and ...growth during the U.S. recession. However, clinics...alth systems are coming closer to having to actual...rators. , (Vocus) Novembe...wing in October despite the shedding of jobs in mo...
Breaking Biology Technology:Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Intelligence inside metal components 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4
...CK, N.J. and NANJING, China, Sept. 3 ,Acesys Pharm...trategic,alliance, combining the drug discovery ex...vid in the US with the medicinal chemistry resourc...., The combined services available through the al...mistry for clients in the pharmaceutical and,biote...
...., Sept. 3 Peregrine,Pharmaceuticals, Inc. (Nasda...s financial results for the first quarter of fisca...and will host a conference call and,webcast to dis...., Peregrine,s senior management will discuss fin..., 2008 and will review recent operating,highlights...
... Are you a strategic planner for an o...estment analyst looking for growth markets? Are y...e in a new niche? Discover the growth segments in ...-25, 2008 at the Charlotte Hilton University Place...arations Society (AFS) will be holding its, fall c...
Other Biology Technology:Acesys and Provid Announce Alliance for Medicinal Chemistry Services 2Peregrine Pharmaceuticals to Report First Quarter FY 2009 Financial Results 2Filter Markets - Discover the Growth Segments 2Filter Markets - Discover the Growth Segments 3
(Date:11/25/2009)...ourse of a lifetime, the heart pumps some 250 mill... to do this, the muscle fibers of the heart have t...by Dr. Wolfgang Rottbauer, vice chair of the Depar...pital (Chairman: Prof. Dr. H. A. Katus), has disco...ity of the smallest muscular unit, the sarcomere. ...
(Date:11/25/2009)..., CAWhen you eat may be just as vital to your heal...Institute for Biological Studies. Their experiment...g of thousands of genes in the liverthe body,s met...ntake and not by the body,s circadian clock as con...ermines the activity of a large number of genes co...
(Date:11/24/2009)...Research Institute (LRI) today named 12 new grant ...lion, recognize innovative work across a broad spe...ir creativity, novelty, and potential to drive sci...d cure the complex disease of systemic lupus. , ...us researchers across the nation and include inter...
Breaking Biology News(10 mins):New genetic cause of cardiac failure discovered 2Feeding the clock 2Feeding the clock 3Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Olympus Managed Health Care Appoints Robert Lavers as Senior Consultant 51508 1Olympus Managed Health Care Appoints Robert Lavers as Senior Consultant 51508 2deCODE Discovers Second Common Genetic Risk Factor for Atrial Fibrillation and Stroke 4719 1deCODE Discovers Second Common Genetic Risk Factor for Atrial Fibrillation and Stroke 4719 2deCODE Discovers Second Common Genetic Risk Factor for Atrial Fibrillation and Stroke 4719 3deCODE Discovers Second Common Genetic Risk Factor for Atrial Fibrillation and Stroke 4719 4Researchers gain insight into mechanism underlying Huntingtons 9240 1Researchers gain insight into mechanism underlying Huntingtons 9240 2
... plant protein and a common insecticide may be mor... alone, according to biologists. The one-two punch...s their chance of developing resistance. , "We fo...es together decreased the growth rate of caterpill...he, professor of plant stress biology at Penn Stat...
...scientists at the Carnegie Institution puts a new ...nt biological process on Earth. Photosynthesis by ...ll living things by producing food from sunlight, ...and absorb carbon dioxide. But two studies by Arth...a et Biophysica Acta and Limnology and Oceanograph...
...hat leverages A-list female beauty to conserve the...s is being launched today at upscale cosmetics cou...cean Science ( http://www.pewoceanscience.org ) is...osmetics company, will donate five percent of the ...ce and Eyes compacts to support vital marine scien...
Other Biology News:Insecticide combo delivers knockout punch 2Insecticide combo delivers knockout punch 3New twist on life's power source 2New twist on life's power source 3Pew Institute teams with Chantecaille Cosmetics to protect global marine life 2
...d stackable multi-function incubator. It uses a mi...n to accurately control temperature and agitation ... temperature in the incubator. Temperature can be ...er. Built in maintenance-free stepping motor for h...
PCR Optimization Kit; Kit for optimization of PCR from Roche Applied Science
...ns is designed for laboratories with limited space...or routine sample preparation and for automation o...put, process consistency and safety. Windows NT b...ntrol the robotic and liquid handling functions an...
Mouse Anti-Human CDC2L5 Monoclonal Antibody, Unconjugated, Clone 1B3-1B11 from Novus Biologicals
Biology Products: